We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$31B
AUM Growth
+$5.1B
Cap. Flow
+$4.42B
Cap. Flow %
14.26%
Top 10 Hldgs %
15.35%
Holding
1,525
New
241
Increased
776
Reduced
376
Closed
66

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 15.7%
3 Healthcare 13.87%
4 Industrials 10.19%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXDX
1351
DELISTED
Ignyta, Inc.
RXDX
$352K ﹤0.01%
+34,000
New +$276K
NWS icon
1352
News Corp Class B
NWS
$17.7B
$351K ﹤0.01%
24,823
HEI icon
1353
HEICO Corp
HEI
$52.1B
$350K ﹤0.01%
9,521
-3,858
-29% -$142K
PR
1354
Permian Resources
PR
$18B
$349K ﹤0.01%
+22,070
New +$363K
PCBK
1355
DELISTED
Pacific Continental Corp
PCBK
$345K ﹤0.01%
13,500
CALA
1356
DELISTED
Calithera Biosciences, Inc
CALA
$342K ﹤0.01%
+1,150
New +$308K
VTLE
1357
DELISTED
Vital Energy
VTLE
$340K ﹤0.01%
1,616
+193
+14% +$47.5K
DVAX
1358
DELISTED
Dynavax Technologies
DVAX
$328K ﹤0.01%
+34,000
New +$221K
CTMX icon
1359
CytomX Therapeutics
CTMX
$760M
$325K ﹤0.01%
+21,000
New +$317K
FHB icon
1360
First Hawaiian
FHB
$3.36B
$324K ﹤0.01%
+10,582
New +$309K
XOG
1361
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$322K ﹤0.01%
+23,971
New +$374K
BCRX icon
1362
BioCryst Pharmaceuticals
BCRX
$2.71B
$311K ﹤0.01%
+56,000
New +$341K
PAG icon
1363
Penske Automotive Group
PAG
$14.3B
$311K ﹤0.01%
7,094
-580
-8% -$25.6K
TVRD
1364
Tvardi Therapeutics
TVRD
$22.1M
$308K ﹤0.01%
+556
New +$353K
EDU icon
1365
New Oriental
EDU
$8.49B
$307K ﹤0.01%
4,362
-4,786
-52% -$329K
GERN icon
1366
Geron
GERN
$1.01B
$305K ﹤0.01%
+110,000
New +$292K
PDLI
1367
DELISTED
PDL BioPharma, Inc.
PDLI
$301K ﹤0.01%
+122,000
New +$281K
ITCI
1368
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$298K ﹤0.01%
+24,000
New +$278K
MORN icon
1369
Morningstar
MORN
$7.41B
$296K ﹤0.01%
3,774
+160
+4% +$12.1K
MCY icon
1370
Mercury Insurance
MCY
$5.84B
$293K ﹤0.01%
5,431
IOVA icon
1371
Iovance Biotherapeutics
IOVA
$3.05B
$287K ﹤0.01%
+39,000
New +$248K
TLGT
1372
DELISTED
Teligent, Inc
TLGT
$284K ﹤0.01%
+3,100
New +$264K
ANIP icon
1373
ANI Pharmaceuticals
ANIP
$1.73B
$281K ﹤0.01%
+6,000
New +$289K
MIXT
1374
DELISTED
MIX TELEMATICS LIMITED
MIXT
$281K ﹤0.01%
35,674
NVTA
1375
DELISTED
Invitae Corporation
NVTA
$277K ﹤0.01%
+29,000
New +$286K

Similar funds

State of Wisconsin Investment Board's Q2 2017 Portfolio in Review

As of Q2 2017, State of Wisconsin Investment Board held 1,525 positions worth $31B, up 20% from $25.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

State of Wisconsin Investment Board deployed $4.42B of net new capital in Q2 2017, opening 241 new positions and adding to 776 existing holdings. Its largest new stake was Altaba Inc: 1,221,540 shares worth $66.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $64.5M trimmed.

  • State of Wisconsin Investment Board's largest Q2 2017 buy was Altaba Inc: 1,221,540 shares worth $66.5M.
  • State of Wisconsin Investment Board added most to Apple in Q2 2017, an estimated $132M increase.
  • State of Wisconsin Investment Board's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $64.5M.
  • State of Wisconsin Investment Board fully exited State Street SPDR S&P Biotech ETF in Q2 2017, selling an estimated $105M.
  • State of Wisconsin Investment Board's ten largest holdings make up 15% of its $31B portfolio in Q2 2017.
  • State of Wisconsin Investment Board opened 241 new positions and closed 66 in Q2 2017.
  • State of Wisconsin Investment Board's portfolio value rose 20% quarter-over-quarter to $31B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2017, filed 3 Aug 2017.